Ming Kuang

8.1k total citations · 3 hit papers
192 papers, 5.0k citations indexed

About

Ming Kuang is a scholar working on Hepatology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ming Kuang has authored 192 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Hepatology, 56 papers in Radiology, Nuclear Medicine and Imaging and 47 papers in Oncology. Recurrent topics in Ming Kuang's work include Hepatocellular Carcinoma Treatment and Prognosis (87 papers), Radiomics and Machine Learning in Medical Imaging (40 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers). Ming Kuang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (87 papers), Radiomics and Machine Learning in Medical Imaging (40 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers). Ming Kuang collaborates with scholars based in China, United States and Hong Kong. Ming Kuang's co-authors include Xiaoyan Xie, Wei Wang, Ming‐De Lu, Sui Peng, Shuling Chen, Baogang Peng, Shaoqiang Li, Zhenwei Peng, Xin Li and Shunli Shen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ming Kuang

181 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma

2023 121 citations Ming Kuang et al. profile →
Effects of digital economy on carbon emission intensity in Chinese cities: A life-cycle theory and the application of non-linear spatial panel smooth transition threshold model

2023 92 citations Ling Bai, Wei Xu et al. Energy Policy profile →
High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT

2024 79 citations Ming Kuang et al. profile →

Peers

Countries citing papers authored by Ming Kuang

Since Specialization

Citations

This map shows the geographic impact of Ming Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Kuang more than expected).

Fields of papers citing papers by Ming Kuang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Kuang. The network helps show where Ming Kuang may publish in the future.

Co-authorship network of co-authors of Ming Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Kuang. A scholar is included among the top collaborators of Ming Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Kuang. Ming Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intrahepatic Microbial Heterogeneity in Multifocal Hepatocellular Carcinoma and Its Association with Host Genomic and Transcriptomic Alterations 2025 ·Cancer Discovery ·Yinghong Lu, Lixia Xu, (unknown), Weixin Liu, (unknown), (unknown), Na Wang, (unknown), (unknown), (unknown), (unknown), Kaili Fu, (unknown), Xin Liu, (unknown), Chi Chun Wong, Ming Kuang, Jun Yu	2
2	Conversion Therapy Based on TACE/HAIC-Based Treatment to Improve the Therapeutic Effect of Initially Unresectable Hepatocellular Carcinoma 2025 ·Liver Cancer ·(unknown), (unknown), (unknown), Yu Xi, Wenxuan Xie, Yunpeng Hua, (unknown), Shunli Shen, Ming Kuang	0
3	Reflecting on Experiences of Senior Medical Students’ External Clinical Teaching Visits in General Practice Placements: A Pilot Study 2024 ·Advances in Medical Education and Practice ·(unknown), Daya Yang, Kunsong Zhang, (unknown), Ming Kuang, Haipeng Xiao, Dan Xu	3
4	Ultrasomics differentiation of malignant and benign focal liver lesions based on contrast-enhanced ultrasound 2024 ·BMC Medical Imaging ·(unknown), Ming‐De Li, Jianchao Zhang, Si‐Min Ruan, Shanshan Wu, (unknown), (unknown), Xiaoyan Xie, (unknown), Ming Kuang, Erjiao Xu, (unknown)	1
5	RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives 2024 ·Nature Reviews Gastroenterology & Hepatology ·Shuibin Lin, Ming Kuang	25
6	A phase Ia/b trial of ARX788 combined with toripalimab for HER2-low advanced breast cancer (ABC) and other HER2-expressing solid tumors. 2024 ·Journal of Clinical Oncology ·Xiying Shao, Ming Kuang, Zhanhong Chen, Yabing Zheng, Guangliang Li, (unknown), Ping Huang, Wen‐Ming Cao, Lixia Xu, Xiaojia Wang	1
7	Perioperative pembrolizumab and lenvatinib for resectable hepatocellular carcinoma: A single-arm, multi-center, phase II trial (NeoLEAP-HCC). 2024 ·Journal of Clinical Oncology ·Hui‐Chuan Sun, Xiaodong Zhu, Kui Wang, Ning Yang, Yongjun Chen, Ming Kuang, Hui Xue, Yingcheng Yang, Feng Ye, Shunli Shen, Cheng Huang, (unknown), Jian Zhou, (unknown)	3
8	Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application 2023 ·Cell Reports Medicine ·Xiaoxue Ren, (unknown), (unknown), Yubin Xie, Yifan Wu, Shenghua Zhu, (unknown), Dongming Li, Jiaming Lai, Shunli Shen, Jie Lin, Ming Kuang, Xiaoxing Li, Jun Yu, Lixia Xu	29
9	Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram 2023 ·European Radiology ·(unknown), Chuan Peng, Hong Ding, Yun Zheng, (unknown), Wei Chen, Xian Zhong, Yifan Shi, Yu Duan, Xiaohua Xie, Ming Kuang, Xiaoyan Xie, Manxia Lin	7
10	945MO AdvanTIG-206: Phase II randomized open-label study of ociperlimab (OCI) + tislelizumab (TIS) + BAT1706 (bevacizumab biosimilar) versus TIS + BAT1706 in patients (pts) with advanced hepatocellular carcinoma (HCC) 2023 ·Annals of Oncology ·Zefang Ren, Yuhua Huang, (unknown), Ming‐Mo Hou, Wei Wang, Ming Kuang, Hao Chen, Yaojun Zhang, Tianqiang Song, (unknown), (unknown), Victor Li, (unknown), Lei Wang, Jun Fan	10
11	METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma 2023 ·Cancer Letters ·Lina Wang, Qingxia Yang, (unknown), Fei Fang, Kai Lei, Ziqin Liu, (unknown), (unknown), (unknown), Xiaoxing Li, Sui Peng, Ming Kuang, Shuibin Lin, Manling Huang, Lixia Xu	84
12	Effects of digital economy on carbon emission intensity in Chinese cities: A life-cycle theory and the application of non-linear spatial panel smooth transition threshold model breakdown → 2023 ·Energy Policy ·Ling Bai, (unknown), Wei Xu, Yaobin Liu, Ming Kuang, Lei Jiang	92
13	Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer 2023 ·Cancer Research ·Zhihang Chen, (unknown), Xiaoxue Ren, (unknown), Qian Zhou, Xuxin Ren, Shuling Chen, Lixia Xu, (unknown), Qianwen Zeng, Ming Kuang, Dong‐Ming Kuang, Sui Peng	33
14	The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma 2023 ·Annals of Surgical Treatment and Research ·(unknown), Man Shu, (unknown), (unknown), (unknown), Jingxian Shen, Ming Kuang, (unknown), (unknown)	2
15	The gut–liver axis in immune remodeling of hepatic cirrhosis 2022 ·Frontiers in Immunology ·(unknown), Xiang Zhang, Ming Kuang, Jun Yu	34
16	Artificial intelligence assists identifying malignant versus benign liver lesions using contrast‐enhanced ultrasound 2021 ·Journal of Gastroenterology and Hepatology ·(unknown), Wei Wang, Li‐Da Chen, Si‐Min Ruan, Shuling Chen, Xin Li, Ming‐De Lu, Xiaoyan Xie, Ming Kuang	46
17	The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas 2020 ·Clinical Cancer Research ·Manling Huang, Minghui He, Yu Guo, Heping Li, Shunli Shen, Yubin Xie, Xiaoxing Li, Han Xiao, (unknown), Dongming Li, Baogang Peng, Lijian Liang, Jun Yu, Ming Kuang, Lixia Xu, Sui Peng	29
18	Ultrasomics for Early Evaluation of the Tumor Response to MicroRNA‐122 in a Nude Mouse Hepatocellular Carcinoma Model 2019 ·Journal of Ultrasound in Medicine ·(unknown), (unknown), Wei Li, Jinyu Liang, (unknown), Xin Li, Xiaoyan Xie, Ming‐De Lu, Ming Kuang, Wei Wang	2
19	Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS 2018 ·European Radiology ·Li‐Da Chen, Si‐Min Ruan, Yuan Lin, Jinyu Liang, Shunli Shen, (unknown), Yang Huang, Wei Li, Zhu Wang, Xiaoyan Xie, Ming‐De Lu, Ming Kuang, Wei Wang	36
20	Decreased Selenium-Binding Protein 1 Enhances Glutathione Peroxidase 1 Activity and Downregulates HIF-1α to Promote Hepatocellular Carcinoma Invasiveness 2012 ·Clinical Cancer Research ·Cheng Zhi Huang, Guangyu Ding, Chengyu Gu, Jian Zhou, Ming Kuang, Yuan Ji, Yifeng He, Tadashi Kondo, Jia Fan	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact